Ovid Therapeutics (OVID) Selling, General & Administrative (2016 - 2026)
Ovid Therapeutics (OVID) Selling, General & Administrative (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Ovid Therapeutics | 121.41 Mn | -34.11 Mn | - | 6.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.67 Mn |
| Dec 31, 2025 | 6.42 Mn |
| Sep 30, 2025 | 6.79 Mn |
| Jun 30, 2025 | 4.88 Mn |
| Mar 31, 2025 | 6.02 Mn |
| Dec 31, 2024 | 4.88 Mn |
| Sep 30, 2024 | 5.54 Mn |
| Jun 30, 2024 | 8.10 Mn |
| Mar 31, 2024 | 7.17 Mn |
| Dec 31, 2023 | 7.69 Mn |
| Sep 30, 2023 | 6.81 Mn |
| Jun 30, 2023 | 8.25 Mn |
| Mar 31, 2023 | 8.34 Mn |
| Dec 31, 2022 | 6.66 Mn |
| Sep 30, 2022 | 7.63 Mn |
| Jun 30, 2022 | 8.26 Mn |
| Mar 31, 2022 | 9.88 Mn |
| Dec 31, 2021 | 8.26 Mn |
| Sep 30, 2021 | 6.76 Mn |
| Jun 30, 2021 | 6.63 Mn |